№ files_lp_4_process_3_081528
File format: docx
Character count: 18797
File size: 513 KB
Year:
2026
Speciality:
Medical Retina
Document Type:
Clinical Review
Author:
Tanya Moutray, Usha Chakravarthy
Categories:
Degenerative
Target Audience:
Ophthalmologists, Retina Specialists
Images Included:
Yes
Key Topics:
Early AMD, Neovascular AMD, Idiopathic Polypoidal Choroidopathy, Risk Factors, Diagnostic Methods, Treatment Considerations
Clinical Signs:
Drusen, RPE changes, Geographic Atrophy, CNV, PED, Hemorrhage
Diagnostic Tools:
Fundus examination, Fluorescein Angiography (FFA), Optical Coherence Tomography (OCT), Indocyanine Green (ICG)
Genetic Factors:
CFH, C3, CCB, ARMS2, SNPs on 10q26, loci 1q, 2p, 3p, 16
Environmental Factors:
Smoking, Dietary antioxidants, Blue light exposure
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2020
Region / City:
Australia
Topic:
Medical Treatment, Pharmaceutical
Document Type:
Submission
Organ / Institution:
Novartis Pharmaceuticals Australia Pty Limited
Author:
Not specified
Target Audience:
Healthcare professionals, policymakers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024-2025
Region / city:
Moshi, Tanzania
Subject:
Diabetic Macular Edema, Intravitreal Bevacizumab
Document Type:
Research Article
Organization / Institution:
Kilimanjaro Christian Medical Centre (KCMC)
Author:
Not specified
Target Audience:
Healthcare professionals, researchers in ophthalmology
Period of Application:
June 2024 - July 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2020
Country:
Australia
Therapeutic Area:
Ophthalmology
Indication:
Diabetic macular oedema (DMO)
Active Substance:
Fluocinolone acetonide 190 microgram intravitreal implant
Brand Name:
Iluvien®
Sponsor:
Specialised Therapeutics Alim Pty Ltd
Regulatory Authority:
Pharmaceutical Benefits Advisory Committee (PBAC)
Registration Status:
TGA registered on 29 July 2019
Type of Submission:
Minor resubmission
Type of Analysis:
Cost-minimisation analysis (CMA)
Comparator:
Dexamethasone intravitreal implant
Restriction Level:
Authority Required – In Writing Only
Treatment Phase:
Initial treatment
Prescriber Type:
Medical practitioners, nurse practitioners, optometrists, midwives, dental practitioners
Program Category:
General Schedule (Code GE)
Clinical Criteria:
Visual impairment due to DMO with specified visual acuity range and prior corticosteroid treatment without significant intraocular pressure rise
Population Criteria:
Patients post-cataract surgery or scheduled for cataract surgery in the treated eye
Document Type:
Public Summary Document extract
Year:
2025
Location:
Andover, UK
Department:
Fundraising
Position Type:
Permanent
Reports To:
Supporter Care Manager
Number of Direct Reports:
0
Financial Responsibility:
Handling cash and banking
Eligibility:
Proof of identity and eligibility to work in the UK
Annual Leave:
26 days plus bank holidays
Skills Required:
Customer care experience, data management, Microsoft Word and Outlook proficiency, teamwork, multitasking
Optional Experience:
Charity sector, Microsoft Dynamics 365
Purpose:
Deliver high-quality supporter care and manage communications with donors, volunteers, and the public
Year:
2026
Field:
Genomics / Molecular Biology
Document Type:
Research Data Table
Organism:
Homo sapiens
Gene Set:
AMDgset
Statistical Methods:
Fisher’s exact test, Benjamini-Hochberg correction
GO Categories:
Molecular Function, Biological Process, Cellular Component
Top Terms Count:
10 per category
Measured Values:
Pa, PBHb, Observed
End Point:
Enrichment analysis of GO terms related to AMD genes
Research Context:
Age-related macular degeneration
Audience:
Biomedical researchers
Data Source:
Experimental gene expression datasets
Description:
A scientific data table listing molecular functions, biological processes, and cellular components significantly enriched in a gene set associated with age-related macular degeneration, including statistical measures for each GO term.
Year:
2026
Region / City:
Global
Topic:
Manuscript Review
Document Type:
Template
Organization / Institution:
AMD
Author:
AMD
Target Audience:
Reviewers
Effective Period:
Ongoing
Approval Date:
2026-02-06
Institution:
Iowa State University
Department:
Apparel, Events, and Hospitality Management Department (AESHM)
Program:
Apparel, Merchandising, and Design (AMD)
Course code:
AMD 165
Course title:
Dress, Appearance, and Diversity in U.S. Society
Semester:
Spring 2022
Course format:
Online and asynchronous
Professor:
Dr. Reddy-Best
Office location:
1058 LeBron Hall
Communication:
Email and Zoom
Prerequisites:
None
Course fee:
None
Required textbook:
None
U.S. Diversity Requirement:
Meets requirement
Assessment components:
Quizzes; Final Exam; Case Studies; Final Student Reflection; Discussion Boards
Policies included:
Grading Scale; Academic Dishonesty; Student Privacy; Emergency Notification; Sexual Misconduct Reporting; Accessibility; Covid-19 Guidelines
Related minor:
Fashion, Culture, History, and Social Justice minor
Year:
2025
Region / City:
USA
Subject:
Legislative amendments
Document Type:
Bill amendment
Agency / Organization:
Washington State Legislature
Author:
Representative Walsh
Target Audience:
Legislators, legal professionals
Effective Period:
2025
Approval Date:
04/11/2025
Amendment Date:
04/11/2025
Year:
2021
Region / City:
United Kingdom
Topic:
Healthcare / Ophthalmology
Document Type:
Referral Form
Organization / Institution:
NHS
Author:
Thames Valley Macular Group
Target Audience:
Optometrists, General Practitioners
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2016
Region / City:
Global
Topic:
Installation Guide
Document Type:
Software Manual
Organization:
AMD
Author:
AMD
Target Audience:
IT Professionals, System Administrators
Period of Validity:
N/A
Approval Date:
2016-11-30
Date of Changes:
2016-11-30
Year:
2025
Region / City:
Washington State
Topic:
Motor Vehicle Registration, Weight Fees
Document Type:
Legislative Amendment
Organization / Institution:
Washington State Legislature
Author:
Representative Fey
Target Audience:
Policymakers, Legislators
Effective Period:
January 1, 2029
Approval Date:
April 24, 2025
Amendment Date:
N/A
Year:
2015
Region / city:
Not specified
Topic:
Legislative amendment
Document type:
Bill amendment
Organization / institution:
Not specified
Author:
Representative Harmsworth
Target audience:
Not specified
Effective period:
Not specified
Approval date:
03/04/2015
Date of changes:
Not specified
Year:
2026
Region / City:
United States
Topic:
Child care subsidy fraud
Document type:
Legislative amendment
Author:
Representative Dufault
Target audience:
Legislators, policymakers, child care providers
Effective period:
Indefinite
Approval date:
02/13/2026
Amendment date:
02/13/2026
Year:
2010
Region / City:
United States
Topic:
Penalty Allocation
Document Type:
Amendment
Author:
Representative Alexander
Target Audience:
Lawmakers, Public Officials
Effective Period:
Not specified
Approval Date:
3/05/2010
Amendment Date:
Not specified